197

Drug Discovery
Sub Categories on Drug Discovery
Latest Articles
DeepMind Open-Sources AlphaFold 3: Transforming the Future of Biological Research and Drug Discovery

DeepMind Open-Sources AlphaFold 3: Transforming the Future of Biological Research and Drug Discovery

DeepMind, the AI-focused subsidiary of Google, has officially open-sourced AlphaFold 3, the latest version of its revolutionary protein structure prediction tool.

DeepMind Open-Sources AlphaFold 3: Transforming the Future of Biological Research and Drug Discovery

DeepMind, the AI-focused subsidiary of Google, has officially open-sourced AlphaFold 3, the latest version of its revolutionary protein structure prediction tool.
Researchers induce brain activation using infrared light-controlled drugs

Researchers induce brain activation using infrared light-controlled drugs

by Institute for Bioengineering of Catalonia (IBEC)Credit: Unsplash/CC0 Public DomainStudying the brain remains one of the most challenging endeavors in neuroscience. Researchers have explored various

Researchers induce brain activation using infrared light-controlled drugs

by Institute for Bioengineering of Catalonia (IBEC)Credit: Unsplash/CC0 Public DomainStudying the brain remains one of the most challenging endeavors in neuroscience. Researchers have explored various
PNAS | AlphaFold2 combined with supercomputing accelerates biophysical discoveries

PNAS | AlphaFold2 combined with supercomputing accelerates biophysical discoveries

The authors deployed APACE on the Delta and Polaris supercomputers and quantified its performance in accurate protein structure prediction using four typical proteins (6AWO, 6OAN, 7MEZ, and 6D6U). Utilizing up to 300 combinations distributed across 200 NV

PNAS | AlphaFold2 combined with supercomputing accelerates biophysical discoveries

The authors deployed APACE on the Delta and Polaris supercomputers and quantified its performance in accurate protein structure prediction using four typical proteins (6AWO, 6OAN, 7MEZ, and 6D6U). Utilizing up to 300 combinations distributed across 200 NV
Can a twice-a-year shot help end the HIV/AIDS epidemic

Can a twice-a-year shot help end the HIV/AIDS epidemic

Science journalist Jon Cohen, physician-scientist Linda-Gail Bekker, and biochemist Wesley Sundquist describe the history of HIV/AIDS prevention and the unique mechanism that led lenacapavir to be named the 2024 Breakthrough of the Year.

Can a twice-a-year shot help end the HIV/AIDS epidemic

Science journalist Jon Cohen, physician-scientist Linda-Gail Bekker, and biochemist Wesley Sundquist describe the history of HIV/AIDS prevention and the unique mechanism that led lenacapavir to be named the 2024 Breakthrough of the Year.
AI-Powered Breakthrough: Novo Nordisk and Valo Health Expand $4.6B Partnership to Revolutionize Cardiometabolic Disease Treatment

AI-Powered Breakthrough: Novo Nordisk and Valo Health Expand $4.6B Partnership to Revolutionize Cardiometabolic Disease Treatment

In a significant expansion of their technological partnership, pharmaceutical giant Novo Nordisk and AI-driven healthcare innovator Valo Health have broadened their collaborative efforts in medical research.

AI-Powered Breakthrough: Novo Nordisk and Valo Health Expand $4.6B Partnership to Revolutionize Cardiometabolic Disease Treatment

In a significant expansion of their technological partnership, pharmaceutical giant Novo Nordisk and AI-driven healthcare innovator Valo Health have broadened their collaborative efforts in medical research.
Science-2024 Breakthrough of the Year:The long shot

Science-2024 Breakthrough of the Year:The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.

Science-2024 Breakthrough of the Year:The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.
Antifungal resistance is not getting nearly as much attention as antibiotic resistance despite similar risks

Antifungal resistance is not getting nearly as much attention as antibiotic resistance despite similar risks

by Norman van Rhijn,The ConversationCredit: CC0 Public DomainFungi are known for causing superficial infections of the nails, skin and hair, but they can also cause systemic infections that can

Antifungal resistance is not getting nearly as much attention as antibiotic resistance despite similar risks

by Norman van Rhijn,The ConversationCredit: CC0 Public DomainFungi are known for causing superficial infections of the nails, skin and hair, but they can also cause systemic infections that can